antpyretic-analgesic and antinlammatory drugs

Upload: kasonda

Post on 06-Apr-2018

235 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    1/38

    ANTIPYRETIC-ANALGESIC AND

    ANTIINFLAMMATORY DRUGSPHARMACOLOGY DEPARTMENT

    DR AYAM R KALINGONJI(MMED 1)FACILITATOR DR RIMOY

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    2/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs)NSAIDs have three major actions,all of which

    are due mainly to the inhibition arachnoic acid

    cyclo-oxygenase in inflammatory cells(the

    COX-2 isoenzyme),and the resultant decreasein prostanoid synthesis.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    3/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs) Ant-inframatory action

    1.The decrease in vasodilator

    prostaglandins(PGE2,PGI2)means less

    vasodilatation and,indirectly,less oedema.

    2.The inhibition of activity of adhesion

    molequle.

    3.Accumulation of inflammatory cells is alsoreduced.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    4/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs) COX:

    COX-1:constitutive enzyme;is involved in

    tissue homeostasis.

    COX-2:inducible enzyme is responsible for the

    production of prostanoid mediators ofinflammation.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    5/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs) ANALGESIC EFFECT:

    -Decreased prostaglandin generation means less

    sensation of nociceptive nerve endings to

    inflammatory mediators such as bradykinin

    and 5-hydroxytryptamine.

    -Relief of headache is probably due to decreased

    prostaglandin-mediated vasodilatation.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    6/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs) ANT-PYRETIC EFFECT:

    -This is partly due to a decreased in the

    mediator prostaglandin that is responsible for

    elevating the hypothalamic set-point for

    temperature control in fever.

    -Endogenous pyogen(IL-1,TNF,IFN,IL-6)

    BBBCNS(PEG.Na+/Ca+.cAMP.CRH)fever

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    7/38

    CLASSIFICATION Selection:Non-selective COX inhibitor

    :selective COX inhibitor

    Chemical constitution;salicylates

    ;acetaminophen

    ;indomethacin

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    8/38

    Non-steroidal ant-inflammatory

    drugs(NSAIDs) Some important examples are

    asprin,ibuprofen,naprexifen,indomethacin,par

    acetamol.(the lastagent has analgesic and

    antipyretic effects but little ant-inflammatoryaction).

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    9/38

    The salicylates:Asprin Asprin(acetylsalicylic acid) was first isolated in

    1829 by Leroux from willow bark.

    It can cause irrevesible inactivation of cyclo-oxygenase,acting on both COX-1 and COX-2

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    10/38

    ASPRIN Salicylates are given orally and are rapidly

    absorbed:75% metabolized in the liver.

    Excretion:85% in alkaline urine

    5% in acidic urine

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    11/38

    Pharmacologic effect 1.Ant-pyretic action

    It is rapidly effective in febrile patients,yet haslittle effect on normal body temperature.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    12/38

    Pharmacologic effect Ant-inflammatory effects.

    The primary clinical application is in the

    treatment of musculoskeletal disorders, such

    as rheumatoid arthritis, osteoarthritis andankylosing spondylitis.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    13/38

    Pharmacologic effects3.Analgesic effect

    (a)Is usually effective for low to moderate

    intensity pain.integumental pain is relieved

    better than the pain from the hollow visceral

    areas.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    14/38

    Pharmacologic effects(b)Relief of pain occur through both peripheral and

    central mechanisms.

    ---peripherally, it inhibits the synthesis of PGs in

    inflamed tissues. Thus prevent the sensitization of

    pain receptors to both chemical and mechanicalstimuli.

    ---centrally the analgesic site exists in close proximity to

    the antipyretic region in the hypothalamus. Its

    analgesia action is not associated with mental

    alterations such as hypnosis or changes in sensation

    other than pain.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    15/38

    Pharmacologic effects4.Respiratory effects

    (a)High dose result in medullary stimulation, leading to

    hyperventilation and respiratory

    alkalosis.compesation rapidly occurs because thekidney is able to increase the excretion of

    bicarbonate, producing compensated respiratory

    alkalosis.

    (b)Toxic doses or very prolonged administration can

    depress the medullary resulting in an compensatedrespiratory acidosis.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    16/38

    Pharmacologic effects5.Cardiovascular effects

    (a)Therapeutic doses have no significant of

    cardiovascular effect. however prophylactic

    use of aspirin to reduce thromboembolic

    event in coronary and cerebral circulation has

    increased. studies have demonstrated that

    such use result in long-term survival andreduced frequency of second myocardialinfarctions.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    17/38

    Pharmacologic effects 5.Cardiovascular effects

    (b)High doses my cause peripheral

    vasodilatation by exerting a direct effect on

    smooth muscle.

    (c)Toxic doses depress circulatory directly and by

    central vasomotor paralysis.non carcinogenic

    pulmonary edema my occur in order patients

    on long term Salicylates therapy.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    18/38

    Pharmacologic effects6.Gastrointestinal effects

    (a)It can cause epigastric distress, nausea and vomiting

    by irritating the gastric mucosal lining and

    stimulating the chemoreceptor trigger zone in the

    CNS.(b)It may cause a dose related gastric ulceration,

    bleeding and erosive gastritis because of inhibiting

    the formation of PGE2,which inhibit gastric acid

    secretion and has a cytoprotective effect.salicylate

    induced gastric bleeding is painless and may lead toiron deficiency anemia.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    19/38

    Pharmacologic effects7.Hepatic effects.

    (a)Dose-dependent hepatic damage usually

    asymptomatic, elevated plasma transaminase

    levels are the key indicator of hepatic insult.

    (b)More severe and associated with

    encephalopathy seen in Reye's syndrome.

    Use of Salicylates in children with chicken pox orinfluenza is contraindicated.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    20/38

    Pharmacologic effects8.Hematologic effects

    (a)It inhibits the platelet aggregation by

    decreasing production of TXA2.

    (b)In doses greater than 6g/dl, aspirin my reduceplasma prothrombin levels.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    21/38

    Pharmacologic effects9.Renal effects;

    It can result in salt and water retention because

    of decreasing renal blood flow.

    10.Metabolic effects;It can produce hyperglycemia and glycosuria in

    larger doses.

    11.Endocrine effect;In very larger doses, it can stimulate steroid

    secretion by the adrenal cortex.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    22/38

    Therapeutic uses1.Asprinis used for the restricted situation for the

    symptomatic relief of fever. Because of an increased

    incidence of Reye's syndrome in children who

    previously were given aspirin for the relief of viralfevers, It is now recommended that a child with any

    fever be given paracetamol instead,ifmedication is

    required.

    2.It is useful as analgesics for certain categories ofpain,such as headache, arthritis and dysmenorrhea.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    23/38

    Therapeutic uses3.It remains the standard, first line drug in the

    therapy of rheumatoid arthritis, and can

    provide relief in the acute rheumatic fever.

    4.Some clinicians recommend small daily doses

    of aspirin for prophylaxis of

    thromboembolism,stroke,or myocardial

    infarction because of its antplatelet activity.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    24/38

    Adverse effects1.salicylism;usually occurs with repeated

    administration with larger doses. Characteristic

    findings include.

    ---headache, mental confusion, lassitude and

    drowsiness.---tinnitus and difficult in hearing.

    ---hyperthermia,sweating,thirst,hyperventilation,

    vomiting and diarrhea.2.Bronchspasmin aspirin-sensitive asthmatics.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    25/38

    Adverse effects3.Gastrointestinal disturbances.

    4.Prolongation of bleeding time or reduce

    prothrombin level.

    5.Other skin eruption, hepatic effects, Reyessyndrome.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    26/38

    Treatment of aspirin poisoning1.Inducing emesis or administering gastric

    lavage.

    2.Appropriate infusion measures to correct

    abnormal electrolyte balance and

    dehydration.

    3.Alkalization of urine.

    4.dialysis as required

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    27/38

    PARACETAMOLPharmacologic effects

    Paracetamol has analgesic and antipyretic actions but

    only weak antinflamatory effects.

    It appears to be an inhibitor of PG synthesis in the

    brain, thus accounting for its analgesic andantipyretic activity.

    It is much less effective than aspirin as an inhibitor of

    peripherally located PG biosynthesis enzyme system

    that plays such an important role in inflammation.

    It exerts little or no pharmacologic effect on the

    cardiovascular,respiratory,or gastrointestinal systems

    on acid base regulation, or on platelet function

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    28/38

    Therapeutic uses Paracetamol provides an effective alternative

    when aspirin is contraindicated(e.g., in patient

    with peptic ulcer or hemophilia)and when the

    antinflamatory action of aspirin is notrequired.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    29/38

    Adverse effects At therapeutic doses paracetamol is well

    tolerated;however,adverse effects includes.

    ---skin rash and drug fever

    ---rare incidence of blood dyscrasias

    ---renal tubular necrosis and renal failure

    ---hypoglycemic coma At overdose, it result in severe Hepatotoxicity,

    and resulting in centrilobular hepatic necrosis.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    30/38

    INDOMETHACIN Pharmacological effects;

    1.Inhibit COX non selectively.

    2.Inhibit phospholipase A and C3.Reduce PMN migration

    4.Decrease B cell ant T cell proliferation

    (10-40 time more potent ant-inflamatory thanaspirin)

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    31/38

    INDOMETHACIN Therapeutic uses;

    Because of its toxicity and side effects, it is not

    routinely used for analgesia antipyretics.

    The major use of indomethacin are in the

    treatment of rheumatoid arthritis, ankylosingspondlytis,osteoarthritis and acute gout.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    32/38

    INDOMETHACIN Adverse effects;

    1.Gastrointestinal complaints

    2.CNS effects; 25%-50%

    3.Hematologic reaction

    4.Hypersensitivity reactions;asthma(asprin-

    sensitive patient may exhibit cross-reactionsto indomethacin)

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    33/38

    Naproxen and ibuprofen They have prominent anti-inflammatory

    action.

    Therapeutic uses; rheumatoid arthritis,

    ankylosing spondlytis,acute tendinitis,

    dysmenorrhea.

    Adverse affect;gastrointerstinal effects,

    dermatologic problems, thrombocytopenia.

    *apply to long term treatment because they arebetter tolerated.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    34/38

    Selective COX -2 inhibitorCelecoxib,meloxicam and Rofenxib

    More selective for COX-2 than COX-1.

    Adverse effects are slighter than other NSADs

    Long term studies of the incidence of clinically

    significant gastrointestinal ulcers and bleedingare not yet compared.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    35/38

    Clinical use of NSAIDs# For analgesia in painfull

    conditions(e.g.headache,dysmenorrhe,backake,boe

    metastasis of cancers,postoperative of pain)

    The drug of choice for short term analgesia areasipinin,paracetamol,ibuprofen,more potent longer

    drugs(diflunisal,naproxem,piroxicam)

    The requirement for narcotic analgesics can be

    markedly reduses by NSAIDs in some patients withbone metastases of post operative pain.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    36/38

    Clinical use of NSAIDs# For antinflamatory effects in chronic or acute

    inflammatory conditions(e.g rheumatoid arthritis

    and renal connective tissue disorders, gout and soft

    tissue disease.)

    With many NSAIDs the dose required for chronicinflammatory disorders is greater than for simple

    analgesia and treatment may need to be continued

    for long periods; treatment could be initiated by an

    agent known to have low incidence of side effects. ifthis proves unsatisfactory, more potent agent should

    be used.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    37/38

    Clinical use of NSAIDs To lower temperature;paracetomol is

    preferred because it lacks gastrointestinal side

    effectsand,unlike aspirin, has not been

    associated with Reyes syndrome in children.

    There is substantial individual variation in

    clinical response to NSAIDs and considerable

    unpredictable patient preference for one drugrather than other.

  • 8/3/2019 Antpyretic-Analgesic and Antinlammatory Drugs

    38/38